BAUDAX BIO INC
COM · CUSIP 07160F107
1
institutional holders
-33 vs Q4 2021
2.9k
shares reported held*
$5.0kreported value*
0 new
0 added
1 reduced
32 sold out
net sold ≈ $22.3m (-12.7m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $1.75.
Trends to Q1 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 64 |
| Q1 2020 | 55 |
| Q2 2020 | 46 |
| Q3 2020 | 33 |
| Q4 2020 | 39 |
| Q1 2021 | 39 |
| Q2 2021 | 40 |
| Q3 2021 | 32 |
| Q4 2021 | 34 |
| Q1 2022 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q2 2020 | 23 | 44 |
| Q3 2020 | 11 | 28 |
| Q4 2020 | 23 | 14 |
| Q1 2021 | 21 | 18 |
| Q2 2021 | 21 | 19 |
| Q3 2021 | 9 | 19 |
| Q4 2021 | 18 | 13 |
| Q1 2022 | 0 | 33 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
CallsPuts
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q2 2021 | $361.0k | $17.0k | 0.05 |
| Q3 2021 | $180.0k | $0 | 0.00 |
| Q4 2021 | $61.0k | $0 | 0.00 |
| Q1 2022 | $0 | $0 | — |
Biggest buyers
| None |
Biggest sellers
| ARMISTICE CAPITAL, LLC | Sold out | -4.7m |
| VANGUARD GROUP INC | Sold out | -3.7m |
| BlackRock Inc. | Sold out | -1.3m |
| GSA CAPITAL PARTNERS LLP | Sold out | -694.3k |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -677.1k |
| STATE STREET CORP | Sold out | -284.6k |
| Amplius Wealth Advisors, LLC | Sold out | -248.4k |
| UBS Group AG | Sold out | -186.3k |
| Virtu Financial LLC | Sold out | -170.5k |
| NORTHERN TRUST CORP | Sold out | -145.8k |
Holders, Q1 2022
| Manager | Shares | Change |
|---|---|---|
| EDMOND DE ROTHSCHILD HOLDING S.A. 0.00% of their portfolio | 2.9k $5.0k | Reduced -97.1k |